PresentationGreat. Thanks, everyone. My name is Etzer Darout, senior biotech analyst at Barclays. It's my pleasure to have enGene with us this morning, CEO, Ronald Cooper. Ron, maybe if you can just give us an introduction of enGene for those that are less familiar with the story, and then we'd take it from there.Ronald H. CooperPresident, CEO & Director Well, enGene is a unique company with unique technology at actually a really unique time, right? So our technology is called the DDX platform. It's a propr ...